{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:48:13Z","timestamp":1791877693860,"version":"4.3.4"},"reference-count":46,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202502CXJD065"],"award-info":[{"award-number":["YDZJ202502CXJD065"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009991","name":"Department of Finance of Jilin Province","doi-asserted-by":"publisher","award":["2024WSZX\u2010B06"],"award-info":[{"award-number":["2024WSZX\u2010B06"]}],"id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Intl Journal of Cancer"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Rising incidence of endometrial cancer among young women has increased the demand for fertility\u2010sparing treatment (FST) in patients with endometrial atypical hyperplasia (EAH) and endometrioid endometrial cancer (EEC). However, approximately 20%\u201330% of patients exhibit progesterone resistance, and reliable predictive biomarkers remain inadequately defined. Therefore, we aimed to identify biomarkers associated with treatment response and prognosis in patients undergoing FST. In this retrospective study, we analyzed 161 patients undergoing mainly progestin\u2010based FST, including 125 with EAH and 36 with G1 EEC. Molecular classification, pretreatment pathological morphology, hormone receptor expression, oncological outcomes, recurrence, and reproductive outcomes were evaluated. According to molecular classification, the cohort included\n                    <jats:italic>POLE<\/jats:italic>\n                    mut (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20092), NSMP (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009143), MMRd (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200911), and p53abn (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20095). Over a median treatment duration of 7\u2009months, molecular classification significantly stratified complete response (CR) rates (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.027), with distinct cumulative CR curves (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.034). Patients with EEC showed lower CR rates than those with EAH (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Reduced CR was associated with extensive lesions, larger lesion diameter, proliferative endometrial background, papillary structure, and squamous metaplasia, whereas morular metaplasia and high estrogen receptor (ER)\/progesterone receptor (PR) expression predicted higher CR rates. Multivariate analysis identified MMRd and squamous metaplasia as independent predictors of recurrence. Within the NSMP subgroup, pathological morphology and PR expression further refined risk stratification. Pregnancy outcomes were comparable across molecular subtypes. These findings suggested that integrating molecular classification with clinicopathological characteristics can improve prognostic assessment and support individualized management for patients undergoing FST.\n                  <\/jats:p>","DOI":"10.1002\/ijc.70785","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:15:20Z","timestamp":1791875720000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular and Clinicopathological Characteristics Predict Fertility\u2010Sparing Treatment Outcomes in Endometrial Atypical Hyperplasia and Endometrioid Endometrial Cancer"],"prefix":"10.1002","author":[{"given":"Tianwei","family":"Xing","sequence":"first","affiliation":[{"name":"Department of Pathology The Second Hospital of Jilin University  Changchun China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Affiliated Hospital of Changchun University of Chinese Medicine  Changchun China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pathology The Second Hospital of Jilin University  Changchun China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathology The Second Hospital of Jilin University  Changchun China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pathology The Second Hospital of Jilin University  Changchun China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwen","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pathology The Second Hospital of Jilin University  Changchun China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7511-3080","authenticated-orcid":false,"given":"Ping\u2010Li","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pathology The Second Hospital of Jilin University  Changchun China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"e_1_2_13_2_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung H.","year":"2021","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"e_1_2_13_3_1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ygyno.2021.04.017","article-title":"Updates on Conservative Management of Endometrial Cancer in Patients Younger Than 45\u2009Years","volume":"161","author":"Lucchini S. M.","year":"2021","journal-title":"Gynecologic Oncology"},{"key":"e_1_2_13_4_1","doi-asserted-by":"crossref","first-page":"669.e1","DOI":"10.1016\/j.ajog.2017.08.007","article-title":"All\u2010Cause Mortality in Young Women With Endometrial Cancer Receiving Progesterone Therapy","volume":"217","author":"Ruiz M. P.","year":"2017","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"e_1_2_13_5_1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Abu\u2010Rustum N.","year":"2023","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"e_1_2_13_6_1","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2021.32.e57","article-title":"Characteristics of Progestin\u2010Insensitive Early Stage Endometrial Cancer and Atypical Hyperplasia Patients Receiving Second\u2010Line Fertility\u2010Sparing Treatment","volume":"32","author":"Zhou S.","year":"2021","journal-title":"Journal of Gynecologic Oncology"},{"key":"e_1_2_13_7_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/IGC.0000000000001164","article-title":"Fertility\u2010Preserving Treatment in Young Women With Grade 1 Presumed Stage IA Endometrial Adenocarcinoma: A Meta\u2010Analysis","volume":"28","author":"Fan Z.","year":"2018","journal-title":"International Journal of Gynecological Cancer"},{"key":"e_1_2_13_8_1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejogrb.2019.07.013","article-title":"Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to Patients Conservatively Treated: Outcomes From an Institutional Series","volume":"240","author":"Falcone F.","year":"2019","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"e_1_2_13_9_1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ygyno.2023.11.006","article-title":"Molecular Subtyping in Endometrial Cancer: A Promising Strategy to Guide Fertility Preservation","volume":"179","author":"Dagher C.","year":"2023","journal-title":"Gynecologic Oncology"},{"key":"e_1_2_13_10_1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.810631","article-title":"Molecular Classification in Patients With Endometrial Cancer After Fertility\u2010Preserving Treatment: Application of ProMisE Classifier and Combination of Prognostic Evidence","volume":"12","author":"Ran X.","year":"2022","journal-title":"Frontiers in Oncology"},{"key":"e_1_2_13_11_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2024.100024","article-title":"The Prognostic Impact of Molecular Classification in Endometrial Cancer That Undergoes Fertility\u2010Sparing Treatment","volume":"35","author":"De Vitis L. A.","year":"2025","journal-title":"International Journal of Gynecological Cancer"},{"key":"e_1_2_13_12_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2012.12.037","article-title":"Progestin Re\u2010Treatment in Patients With Recurrent Endometrial Adenocarcinoma After Successful Fertility\u2010Sparing Management Using Progestin","volume":"129","author":"Park J. Y.","year":"2013","journal-title":"Gynecologic Oncology"},{"key":"e_1_2_13_13_1","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/PAS.0b013e31802d68ce","article-title":"Histologic Alterations in Endometrial Hyperplasia and Well\u2010Differentiated Carcinoma Treated With Progestins","volume":"31","author":"Wheeler D. T.","year":"2007","journal-title":"American Journal of Surgical Pathology"},{"key":"e_1_2_13_14_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/PGP.0b013e31826129e1","article-title":"Immunohistochemical Characterization of Squamous Differentiation and Morular Metaplasia in Uterine Endometrioid Adenocarcinoma","volume":"32","author":"Blanco L. Z.","year":"2013","journal-title":"International Journal of Gynecological Pathology"},{"key":"e_1_2_13_15_1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00404-021-06382-3","article-title":"Clinical Implications of Morular Metaplasia in Fertility\u2010Preserving Treatment for Atypical Endometrial Hyperplasia and Early Endometrial Carcinoma Patients","volume":"306","author":"Wu P.","year":"2022","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"e_1_2_13_16_1","volume-title":"Female Genital Tumours","author":"Board WCoTE","year":"2020"},{"key":"e_1_2_13_17_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated Genomic Characterization of Endometrial Carcinoma","volume":"497","author":"Kandoth C.","year":"2013","journal-title":"Nature"},{"key":"e_1_2_13_18_1","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2023.34.e85","article-title":"FIGO Staging of Endometrial Cancer: 2023","volume":"34","author":"Berek J. S.","year":"2023","journal-title":"Journal of Gynecologic Oncology"},{"key":"e_1_2_13_19_1","doi-asserted-by":"crossref","first-page":"370.e1","DOI":"10.1016\/j.ajog.2020.10.003","article-title":"Mismatch Repair Status Influences Response to Fertility\u2010Sparing Treatment of Endometrial Cancer","volume":"224","author":"Chung Y. S.","year":"2021","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"e_1_2_13_20_1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112847","article-title":"Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial Neoplasia","volume":"13","author":"Puechl A. M.","year":"2021","journal-title":"Cancers (Basel)"},{"key":"e_1_2_13_21_1","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoac057","article-title":"ESGO\/ESHRE\/ESGE Guidelines for the Fertility\u2010Sparing Treatment of Patients With Endometrial Carcinoma","volume":"2023","author":"Rodolakis A.","year":"2023","journal-title":"Human Reproduction Open"},{"key":"e_1_2_13_22_1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of Somatic POLE Mutations in Endometrial Carcinoma","volume":"250","author":"Le\u00f3n\u2010Castillo A.","year":"2020","journal-title":"Journal of Pathology"},{"issue":"1","key":"e_1_2_13_23_1","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility","volume":"38","author":"K\u00f6bel M.","year":"2019","journal-title":"International Journal of Gynecological Pathology"},{"key":"e_1_2_13_24_1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00428-022-03367-8","article-title":"A 2\u2010Tier Subdivision of Papillary Proliferations of the Endometrium (PPE) Only Emphasizing the Complexity of Papillae Precisely Predicts the Neoplastic Risk and Reflects the Neoplasia\u2010Related Molecular Characteristics\u2010a Single\u2010Centered Analysis of 207 Cases","volume":"481","author":"Liu D.","year":"2022","journal-title":"Virchows Archiv"},{"key":"e_1_2_13_25_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154278","article-title":"Application of Molecular Classification to Guiding Fertility\u2010Sparing Therapy for Patients With Endometrial Cancer or Endometrial Intraepithelial Neoplasia","volume":"241","author":"Zhang X.","year":"2023","journal-title":"Pathology, Research and Practice"},{"key":"e_1_2_13_26_1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/his.12249","article-title":"Reproducibility of Current Classifications of Endometrial Endometrioid Glandular Proliferations: Further Evidence Supporting a Simplified Classification","volume":"64","author":"Ordi J.","year":"2014","journal-title":"Histopathology"},{"key":"e_1_2_13_27_1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1309\/AJCPM2TSDDF1MHBZ","article-title":"Assessing Endometrial Hyperplasia and Carcinoma Treated With Progestin Therapy","volume":"138","author":"Mentrikoski M. J.","year":"2012","journal-title":"American Journal of Clinical Pathology"},{"key":"e_1_2_13_28_1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/path.4160","article-title":"Alterations in Wnt\u2010\u03b2\u2010Catenin and Pten Signalling Play Distinct Roles in Endometrial Cancer Initiation and Progression","volume":"230","author":"Zee M.","year":"2013","journal-title":"Journal of Pathology"},{"key":"e_1_2_13_29_1","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2023.34.e53","article-title":"PTEN Mutation Predicts Unfavorable Fertility Preserving Treatment Outcome in the Young Patients With Endometrioid Endometrial Cancer and Atypical Hyperplasia","volume":"34","author":"Xue Y.","year":"2023","journal-title":"Journal of Gynecologic Oncology"},{"key":"e_1_2_13_30_1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1282356","article-title":"Outcomes of Fertility Preservation Treatments in Patients With Endometrial Cancer With Different Molecular Classifications Based on an NGS Panel","volume":"13","author":"Xu Y.","year":"2023","journal-title":"Frontiers in Oncology"},{"key":"e_1_2_13_31_1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/aogs.13586","article-title":"Should Progesterone and Estrogen Receptors Be Assessed for Predicting the Response to Conservative Treatment of Endometrial Hyperplasia and Cancer? A Systematic Review and Meta\u2010Analysis","volume":"98","author":"Raffone A.","year":"2019","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"e_1_2_13_32_1","doi-asserted-by":"crossref","DOI":"10.1177\/15330338251349972","article-title":"Comprehensive Genomic and Immunohistochemical Profiling to Predict Prognosis and Recurrence in Fertility\u2010Sparing Therapy Based on Progesterone for Endometrial Carcinoma","volume":"24","author":"Yang L.","year":"2025","journal-title":"Technology in Cancer Research & Treatment"},{"key":"e_1_2_13_33_1","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2024.35.e27","article-title":"Efficacy of Fertility\u2010Sparing Treatment With LNG\u2010IUS Is Associated With Different ProMisE Subtypes of Endometrial Carcinoma or Atypical Endometrial Hyperplasia","volume":"35","author":"Lv X.","year":"2023","journal-title":"Journal of Gynecologic Oncology"},{"key":"e_1_2_13_34_1","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2025.36.e59","article-title":"Fertility\u2010Sparing Treatment Outcomes Using Immune Checkpoint Inhibitors in Endometrial Cancer Patients With Lynch Syndrome","volume":"36","author":"Yang X.","year":"2025","journal-title":"Journal of Gynecologic Oncology"},{"key":"e_1_2_13_35_1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ygyno.2024.10.012","article-title":"Molecular Classification in Fertility\u2010Sparing Treatment of Early\u2010Stage Endometrial Cancer: A Potential Tool for Optimizing Patient Selection","volume":"191","author":"Peng S.","year":"2024","journal-title":"Gynecologic Oncology"},{"key":"e_1_2_13_36_1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/his.13338","article-title":"Blinded Histopathological Characterisation of POLE Exonuclease Domain\u2010Mutant Endometrial Cancers: Sheep in Wolf's Clothing","volume":"72","author":"Van Gool I. C.","year":"2018","journal-title":"Histopathology"},{"key":"e_1_2_13_37_1","doi-asserted-by":"crossref","first-page":"57642","DOI":"10.18632\/oncotarget.17588","article-title":"Comparison Among Fertility\u2010Sparing Therapies for Well Differentiated Early\u2010Stage Endometrial Carcinoma and Complex Atypical Hyperplasia","volume":"8","author":"Zhang Q.","year":"2017","journal-title":"Oncotarget"},{"key":"e_1_2_13_38_1","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71875","article-title":"Efficacy of Fertility\u2010Sparing Treatment With Progestin Is Associated With Different Molecular Classification in Endometrial Carcinoma and Atypical Endometrial Hyperplasia","volume":"15","author":"Qian X. Q.","year":"2026","journal-title":"Cancer Medicine"},{"key":"e_1_2_13_39_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejogrb.2024.09.006","article-title":"Fertility\u2010Sparing Treatment in MSI\u2010H\/MMRd Endometrial Carcinoma or Atypical Endometrial Hyperplasia: A Systematic Review and Meta\u2010Analysis","volume":"302","author":"Zhang T.","year":"2024","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"e_1_2_13_40_1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2011.06.005","article-title":"Clinicopathologic Significance of DNA Mismatch Repair Protein Defects and Endometrial Cancer in Women 40 Years of Age and Younger","volume":"123","author":"Shih K. K.","year":"2011","journal-title":"Gynecologic Oncology"},{"key":"e_1_2_13_41_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100045","article-title":"ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis","volume":"36","author":"Asaka S.","year":"2023","journal-title":"Modern Pathology"},{"key":"e_1_2_13_42_1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1634\/theoncologist.2019-0837","article-title":"It Is Time to Talk About Fertility and Immunotherapy","volume":"25","author":"Duma N.","year":"2020","journal-title":"Oncologist"},{"key":"e_1_2_13_43_1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PGP.0000000000001113","article-title":"Molecular Subtype and Mutational Profile of Endometrial Atypical Hyperplasia\/Endometrioid Intraepithelial Neoplasia","volume":"45","author":"Leino A.","year":"2026","journal-title":"International Journal of Gynecological Pathology"},{"key":"e_1_2_13_44_1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2019.08.019","article-title":"TCGA Molecular Groups of Endometrial Cancer: Pooled Data About Prognosis","volume":"155","author":"Raffone A.","year":"2019","journal-title":"Gynecologic Oncology"},{"key":"e_1_2_13_45_1","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32060317","article-title":"Molecular Classification Guides Fertility\u2010Sparing Treatment for Endometrial Cancer and Atypical Hyperplasia Patients","volume":"32","author":"Wang Y.","year":"2025","journal-title":"Current Oncology"},{"key":"e_1_2_13_46_1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01437","article-title":"Fertility\u2010Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma","volume":"10","author":"Yu M.","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"e_1_2_13_47_1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ygyno.2026.06.019","article-title":"Fertility\u2010Sparing Treatment in Stage IA Grade 2 Endometrioid Endometrial Cancer: Outcomes of a Standardized Approach","volume":"211","author":"Catena U.","year":"2026","journal-title":"Gynecologic Oncology"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.70785","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ijc.70785","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.70785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:15:27Z","timestamp":1791875727000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.70785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":46,"alternative-id":["10.1002\/ijc.70785"],"URL":"https:\/\/doi.org\/10.1002\/ijc.70785","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"2026-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"ijc.70785"}}